US Patent Issued to Orionis Biosciences, VIB VZW, Universiteit Gent on July 22 for "CD8 binding agents" (Belgian, American Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,753, issued on July 22, was assigned to Orionis Biosciences BV (Ghent, Belgium), VIB VZW (Ghent, Belgium) and Universiteit Gent (Ghent, Belgium).

"CD8 binding agents" was invented by Nikolai Kley (Waltham, Mass.), Jan Tavernier (Balegem, Belgium), Anje Cauwels (Merelbeke, Belgium) and Sarah Gerlo (Ghent, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to agents that bind CD8 and their use as therapeutic and diagnostic agents. The present invention further relates to pharmaceutical compositions comprising the CD8 binding agents and their use in the treatment of various diseases, including, for example, c...